CD8A and neoplasm: In a pre-clinical immunocompetent mouse model with subcutaneous PDAC, stereotactic body radiotherapy (SBRT) in combination with intra-tumoral injections of IL-12 microspheres resulted in increased IFN production and CD8+ T-cell activation, followed by significant tumor reduction and even remission in some cases [113].